Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / Ordinary Shares, nominal value 0.05 GBP per share
-
Shares outstanding
-
84,213,667
-
Total 13F shares
-
60,335,461
-
Share change
-
+8,522,182
-
Total reported value
-
$1,211,517,782
-
Put/Call ratio
-
124%
-
Price per share
-
$20.08
-
Number of holders
-
93
-
Value change
-
+$167,801,714
-
Number of buys
-
57
-
Number of sells
-
32
Institutional Holders of Verona Pharma plc - Ordinary Shares, nominal value 0.05 GBP per share (VRNA) as of Q1 2023
As of 31 Mar 2023,
Verona Pharma plc - Ordinary Shares, nominal value 0.05 GBP per share (VRNA) was held by
93 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
60,335,461 shares.
The largest 10 holders included
RA CAPITAL MANAGEMENT, L.P., NEA Management Company, LLC, FMR LLC, ORBIMED ADVISORS LLC, Vivo Capital, LLC, WELLINGTON MANAGEMENT GROUP LLP, Deep Track Capital, LP, Fairmount Funds Management LLC, Frazier Life Sciences Management, L.P., and PERCEPTIVE ADVISORS LLC.
This page lists
93
institutional shareholders reporting positions in this security
for the Q1 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.